Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats

Journal of Nutritional Biochemistry

Volumn 18, Issue 10, 2007, Pages 676-684

  Purushotham, Aparna ^a   Shrode, Gayle E ^a   Wendel, Angela A ^a   Liu, Li Fen ^a   Belury, Martha A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Conjugated linoleic acid; Hepatic steatosis; Lipogenesis

Indexed keywords

ACETYL COENZYME A OXIDASE; ACYL COENZYME A DESATURASE; CONJUGATED LINOLEIC ACID; ENZYME; FATTY ACID SYNTHASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SOYBEAN OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; FATTY LIVER; GENE EXPRESSION; LIPID STORAGE; LIPOGENESIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; RAT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS, UNSATURATED; FATTY LIVER; LINOLEIC ACIDS, CONJUGATED; LIPID METABOLISM; LIVER; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

GLYCINE MAX; RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 34548527932     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.10.008     Document Type: Article

References (43)

1. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
2. Samuel V.T., Liu Z.X., Qu X., et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279 (2004) 32345-32353
3. Pariza M.W., and Ha Y.L. Conjugated dienoic derivatives of linoleic acid: a new class of anticarcinogens. Med Oncol Tumor Pharmacother 7 (1990) 169-171
4. Evans M., Brown J., and McIntosh M. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem 13 (2002) 508
5. House R.L., Cassady J.P., Eisen E.J., McIntosh M.K., and Odle J. Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes Rev 6 (2005) 247-258
6. Nagao K., Inoue N., Wang Y.M., Shirouchi B., and Yanagita T. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr 135 (2005) 9-13
7. Rahman S.M., Huda M.N., Uddin M.N., and Akhteruzzaman S. Short-term administration of conjugated linoleic acid reduces liver triglyceride concentration and phosphatidate phosphohydrolase activity in OLETF rats. J Biochem Mol Biol 35 (2002) 494-497
8. Wendel A.A., and Belury M.A. Effects of conjugated linoleic acid and troglitazone on lipid accumulation and composition in lean and Zucker diabetic fatty (fa/fa) rats. Lipids 41 (2006) 241-247
9. Wang Y.M., Nagao K., Inoue N., et al. Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats. Biosci Biotechnol Biochem 70 (2006) 355-362
10. Ryder J.W., Portocarrero C.P., Song X.M., et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50 (2001) 1149-1157
11. Buettner R., Newgard C.B., Rhodes C.J., and O'Doherty R.M. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab 278 (2000) E563-E569
12. Buettner R., Ottinger I., Scholmerich J., and Bollheimer L.C. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 286 (2004) E828-E833
13. Mirand P.P., Arnal-Bagnard M.A., Mosoni L., Faulconnier Y., Chardigny J.M., and Chilliard Y. Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers do not modify body composition in adult sedentary or exercised rats. J Nutr 134 (2004) 2263-2269
14. Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., and Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res 40 (1999) 1426-1433
15. Belury M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 22 (2002) 505-531
16. Roche H.M., Noone E., Sewter C., et al. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes 51 (2002) 2037-2044
17. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
18. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
19. Folch J., Lees M., and Sloane Stanley H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
20. Hamilton J.G., and Comai K. Rapid separation of neutral lipids, free fatty acids and polar lipids using prepacked silica Sep-Pak columns. Lipids 23 (1988) 1146-1149
21. Attie A.D., Krauss R.M., Gray-Keller M.P., et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43 (2002) 1899-1907
22. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49 (2000) 1534-1542
23. Poirier H., Rouault C., Clement L., et al. Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic beta cell hyperplasia in the mouse. Diabetologia 48 (2005) 1059-1065
24. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40 (1999) 1549-1558
25. Tsuboyama-Kasaoka N., Miyazaki H., Kasaoka S., and Ezaki O. Increasing the amount of fat in a conjugated linoleic acid-supplemented diet reduces lipodystrophy in mice. J Nutr 133 (2003) 1793-1799
26. Festi D., Colecchia A., Sacco T., Bondi M., Roda E., and Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5 (2004) 27-42
27. Koba K., Akahoshi A., Yamasaki M., et al. Dietary conjugated linolenic acid in relation to CLA differently modifies body fat mass and serum and liver lipid levels in rats. Lipids 37 (2002) 343-350
28. Mizunoya W., Haramizu S., Shibakusa T., Okabe Y., and Fushiki T. Dietary conjugated linoleic acid increases endurance capacity and fat oxidation in mice during exercise. Lipids 40 (2005) 265-271
29. Lee K.N., Pariza M.W., and Ntambi J.M. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression. Biochem Biophys Res Commun 248 (1998) 817-821
30. Lin X., Loor J.J., and Herbein J.H. Trans10,cis12-18:2 is a more potent inhibitor of de novo fatty acid synthesis and desaturation than cis9,trans11-18:2 in the mammary gland of lactating mice. J Nutr 134 (2004) 1362-1368
31. Yeon J.E., Choi K.M., Baik S.H., et al. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 19 (2004) 799-804
32. Sanyal A.J., Campbell-Sargent C., Mirshahi F., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
33. Choi Y., Park Y., Pariza M.W., and Ntambi J.M. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem Biophys Res Commun 284 (2001) 689-693
34. Choi Y., Kim Y.C., Han Y.B., Park Y., Pariza M.W., and Ntambi J.M. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J Nutr 130 (2000) 1920-1924
35. Ntambi J.M., and Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 43 (2004) 91-104
36. Dobrzyn P., Dobrzyn A., Miyazaki M., et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 101 (2004) 6409-6414
37. Kang K., Miyazaki M., Ntambi J.M., and Pariza M.W. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity. Biochem Biophys Res Commun 315 (2004) 532-537
38. Levy J.R., Clore J.N., and Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 39 (2004) 608-616
39. Bays H., Mandarino L., and DeFronzo R.A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89 (2004) 463-478
40. Ceddia R.B., Lopes G., Souza H.M., et al. Acute effects of leptin on glucose metabolism of in situ rat perfused livers and isolated hepatocytes. Int J Obes Relat Metab Disord 23 (1999) 1207-1212
41. Ceddia R.B., William Jr. W.N., and Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 23 (1999) 75-82
42. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 (2001) 947-953
43. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451